| Great Care Health Services Llc | |
|
435 Metroplex Dr Ste 211 Nashville TN 37211-3109 | |
| (615) 682-8150 | |
| Not Available |
| Full Name | Great Care Health Services Llc |
|---|---|
| Speciality | Community/Behavioral Health |
| Location | 435 Metroplex Dr Ste 211, Nashville, Tennessee |
| Authorized Official Name and Position | Claude Gatebuke (DIRECTOR) |
| Authorized Official Contact | 6156828150 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Great Care Health Services Llc 435 Metroplex Dr Ste 211 Nashville TN 37211-3109 Ph: (161) 568-2815 | Great Care Health Services Llc 435 Metroplex Dr Ste 211 Nashville TN 37211-3109 Ph: (615) 682-8150 |
| NPI Number | 1013692797 |
|---|---|
| Provider Enumeration Date | 06/20/2023 |
| Last Update Date | 07/20/2023 |
| Certification Date | 07/20/2023 |
| Medicare PECOS PAC ID | 1254793003 |
|---|---|
| Medicare Enrollment ID | O20230811000244 |
News Archive
Scientists in Cambridge have discovered that the loss of a key segment of DNA can lead to severe childhood obesity. This is the first study to show that this kind of genetic alteration can cause obesity. The results are published today in Nature.
A newly developed technique allows researchers to more easily study malaria outside the human body during the earliest point of infection, the liver.
Some patients infected with the novel coronavirus may experience only mild symptoms, while others may need medical care due to severe illness. People who are at a high risk of developing severe coronavirus disease (COVID-19) include older adults and those with underlying health conditions. However, severe disease has also been seen in young people with no underlying disease.
British smokers thinking of quitting have a reason to celebrate this New Year. Free nicotine patches are to be offered on the NHS as part of a major drive to help smokers quit. The Department of Health has announced that smokers would be given coupons for a week's free trial of the patches in the "Quit kits". The patches included in the kit will be either NiQuitin Clear 21mg patches or Nicotinell TTS 30 21mg/24 hour patches, Step 1.
Sosei Group Corporation, the biopharmaceutical company, today announced that Sosei R&D Ltd., its wholly owned UK subsidiary, has entered into an agreement to assign its rights to the assets of AD 923, an optimised, sublingual formulation of the opioid analgesic fentanyl for the treatment of cancer breakthrough pain, as well as to the device for drug administration to Pharmasol R&D Ltd., a privately held UK company.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013692797 | NPI | - | NPPES |
| Provider Name | Anthony C Ekwo |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1114209301 PECOS PAC ID: 0143596924 Enrollment ID: I20171023001772 |
News Archive
Scientists in Cambridge have discovered that the loss of a key segment of DNA can lead to severe childhood obesity. This is the first study to show that this kind of genetic alteration can cause obesity. The results are published today in Nature.
A newly developed technique allows researchers to more easily study malaria outside the human body during the earliest point of infection, the liver.
Some patients infected with the novel coronavirus may experience only mild symptoms, while others may need medical care due to severe illness. People who are at a high risk of developing severe coronavirus disease (COVID-19) include older adults and those with underlying health conditions. However, severe disease has also been seen in young people with no underlying disease.
British smokers thinking of quitting have a reason to celebrate this New Year. Free nicotine patches are to be offered on the NHS as part of a major drive to help smokers quit. The Department of Health has announced that smokers would be given coupons for a week's free trial of the patches in the "Quit kits". The patches included in the kit will be either NiQuitin Clear 21mg patches or Nicotinell TTS 30 21mg/24 hour patches, Step 1.
Sosei Group Corporation, the biopharmaceutical company, today announced that Sosei R&D Ltd., its wholly owned UK subsidiary, has entered into an agreement to assign its rights to the assets of AD 923, an optimised, sublingual formulation of the opioid analgesic fentanyl for the treatment of cancer breakthrough pain, as well as to the device for drug administration to Pharmasol R&D Ltd., a privately held UK company.
› Verified 3 days ago
| Provider Name | Eboni Burns |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1225431950 PECOS PAC ID: 7113270547 Enrollment ID: I20181031002624 |
News Archive
Scientists in Cambridge have discovered that the loss of a key segment of DNA can lead to severe childhood obesity. This is the first study to show that this kind of genetic alteration can cause obesity. The results are published today in Nature.
A newly developed technique allows researchers to more easily study malaria outside the human body during the earliest point of infection, the liver.
Some patients infected with the novel coronavirus may experience only mild symptoms, while others may need medical care due to severe illness. People who are at a high risk of developing severe coronavirus disease (COVID-19) include older adults and those with underlying health conditions. However, severe disease has also been seen in young people with no underlying disease.
British smokers thinking of quitting have a reason to celebrate this New Year. Free nicotine patches are to be offered on the NHS as part of a major drive to help smokers quit. The Department of Health has announced that smokers would be given coupons for a week's free trial of the patches in the "Quit kits". The patches included in the kit will be either NiQuitin Clear 21mg patches or Nicotinell TTS 30 21mg/24 hour patches, Step 1.
Sosei Group Corporation, the biopharmaceutical company, today announced that Sosei R&D Ltd., its wholly owned UK subsidiary, has entered into an agreement to assign its rights to the assets of AD 923, an optimised, sublingual formulation of the opioid analgesic fentanyl for the treatment of cancer breakthrough pain, as well as to the device for drug administration to Pharmasol R&D Ltd., a privately held UK company.
› Verified 3 days ago
| Provider Name | Whitney S Evans |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1386179943 PECOS PAC ID: 2062782881 Enrollment ID: I20220314000467 |
News Archive
Scientists in Cambridge have discovered that the loss of a key segment of DNA can lead to severe childhood obesity. This is the first study to show that this kind of genetic alteration can cause obesity. The results are published today in Nature.
A newly developed technique allows researchers to more easily study malaria outside the human body during the earliest point of infection, the liver.
Some patients infected with the novel coronavirus may experience only mild symptoms, while others may need medical care due to severe illness. People who are at a high risk of developing severe coronavirus disease (COVID-19) include older adults and those with underlying health conditions. However, severe disease has also been seen in young people with no underlying disease.
British smokers thinking of quitting have a reason to celebrate this New Year. Free nicotine patches are to be offered on the NHS as part of a major drive to help smokers quit. The Department of Health has announced that smokers would be given coupons for a week's free trial of the patches in the "Quit kits". The patches included in the kit will be either NiQuitin Clear 21mg patches or Nicotinell TTS 30 21mg/24 hour patches, Step 1.
Sosei Group Corporation, the biopharmaceutical company, today announced that Sosei R&D Ltd., its wholly owned UK subsidiary, has entered into an agreement to assign its rights to the assets of AD 923, an optimised, sublingual formulation of the opioid analgesic fentanyl for the treatment of cancer breakthrough pain, as well as to the device for drug administration to Pharmasol R&D Ltd., a privately held UK company.
› Verified 3 days ago
| Provider Name | Bonaventure Nwabueze Anikwe |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568052645 PECOS PAC ID: 8729445127 Enrollment ID: I20230530002397 |
News Archive
Scientists in Cambridge have discovered that the loss of a key segment of DNA can lead to severe childhood obesity. This is the first study to show that this kind of genetic alteration can cause obesity. The results are published today in Nature.
A newly developed technique allows researchers to more easily study malaria outside the human body during the earliest point of infection, the liver.
Some patients infected with the novel coronavirus may experience only mild symptoms, while others may need medical care due to severe illness. People who are at a high risk of developing severe coronavirus disease (COVID-19) include older adults and those with underlying health conditions. However, severe disease has also been seen in young people with no underlying disease.
British smokers thinking of quitting have a reason to celebrate this New Year. Free nicotine patches are to be offered on the NHS as part of a major drive to help smokers quit. The Department of Health has announced that smokers would be given coupons for a week's free trial of the patches in the "Quit kits". The patches included in the kit will be either NiQuitin Clear 21mg patches or Nicotinell TTS 30 21mg/24 hour patches, Step 1.
Sosei Group Corporation, the biopharmaceutical company, today announced that Sosei R&D Ltd., its wholly owned UK subsidiary, has entered into an agreement to assign its rights to the assets of AD 923, an optimised, sublingual formulation of the opioid analgesic fentanyl for the treatment of cancer breakthrough pain, as well as to the device for drug administration to Pharmasol R&D Ltd., a privately held UK company.
› Verified 3 days ago
| Provider Name | Angela P Tamayo |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1144094350 PECOS PAC ID: 1951752351 Enrollment ID: I20240110002652 |
News Archive
Scientists in Cambridge have discovered that the loss of a key segment of DNA can lead to severe childhood obesity. This is the first study to show that this kind of genetic alteration can cause obesity. The results are published today in Nature.
A newly developed technique allows researchers to more easily study malaria outside the human body during the earliest point of infection, the liver.
Some patients infected with the novel coronavirus may experience only mild symptoms, while others may need medical care due to severe illness. People who are at a high risk of developing severe coronavirus disease (COVID-19) include older adults and those with underlying health conditions. However, severe disease has also been seen in young people with no underlying disease.
British smokers thinking of quitting have a reason to celebrate this New Year. Free nicotine patches are to be offered on the NHS as part of a major drive to help smokers quit. The Department of Health has announced that smokers would be given coupons for a week's free trial of the patches in the "Quit kits". The patches included in the kit will be either NiQuitin Clear 21mg patches or Nicotinell TTS 30 21mg/24 hour patches, Step 1.
Sosei Group Corporation, the biopharmaceutical company, today announced that Sosei R&D Ltd., its wholly owned UK subsidiary, has entered into an agreement to assign its rights to the assets of AD 923, an optimised, sublingual formulation of the opioid analgesic fentanyl for the treatment of cancer breakthrough pain, as well as to the device for drug administration to Pharmasol R&D Ltd., a privately held UK company.
› Verified 3 days ago
News Archive
Scientists in Cambridge have discovered that the loss of a key segment of DNA can lead to severe childhood obesity. This is the first study to show that this kind of genetic alteration can cause obesity. The results are published today in Nature.
A newly developed technique allows researchers to more easily study malaria outside the human body during the earliest point of infection, the liver.
Some patients infected with the novel coronavirus may experience only mild symptoms, while others may need medical care due to severe illness. People who are at a high risk of developing severe coronavirus disease (COVID-19) include older adults and those with underlying health conditions. However, severe disease has also been seen in young people with no underlying disease.
British smokers thinking of quitting have a reason to celebrate this New Year. Free nicotine patches are to be offered on the NHS as part of a major drive to help smokers quit. The Department of Health has announced that smokers would be given coupons for a week's free trial of the patches in the "Quit kits". The patches included in the kit will be either NiQuitin Clear 21mg patches or Nicotinell TTS 30 21mg/24 hour patches, Step 1.
Sosei Group Corporation, the biopharmaceutical company, today announced that Sosei R&D Ltd., its wholly owned UK subsidiary, has entered into an agreement to assign its rights to the assets of AD 923, an optimised, sublingual formulation of the opioid analgesic fentanyl for the treatment of cancer breakthrough pain, as well as to the device for drug administration to Pharmasol R&D Ltd., a privately held UK company.
› Verified 3 days ago
Surpass Behavioral Health Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4017 Hillsboro Pike Ste 418, Nashville, TN 37215 Phone: 615-696-6761 Fax: 615-880-5782 | |
Nashville Psychological Assessment And Learning Associates Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 805 Bradford Ave, Nashville, TN 37204 Phone: 615-988-0194 | |
Thrive Consulting Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 210 25th Ave N Ste 1220, Nashville, TN 37203 Phone: 615-549-5033 | |
Nashville Therapt For Women Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 169 Belle Forest Cir Ste A, Nashville, TN 37221 Phone: 615-516-2323 | |
Athena Consulting And Psychological Services, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 220 Athens Way Ste 104, Nashville, TN 37228 Phone: 615-320-1155 Fax: 615-320-1177 | |
Blue Gems Aba Tn Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 40 Burton Hills Blvd Ste 200, Nashville, TN 37215 Phone: 617-297-7998 | |
W Garrison Strickland Md, Pc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 300 20th Ave N, Suite 600, Nashville, TN 37203 Phone: 615-284-2214 Fax: 615-284-2314 |